Chemycal has been acquired by 3E
Learn MoreDiscover how Chemycal PRO helps you boosting your regulatory monitoring:
EFSA's Scientific Committee has launched an open consultation on a Scientific Committee guidance on the assessment of aneugenicity. This document discusses the most appropriate in vivo follow-up for substances that are found to be aneugenic in vitro and how should the risk to human health be assessed for aneugenic substances.
CONTINUE READING ON www.efsa.europa.eu
2013 © MyChemicalMonitoring. ALL Rights Reserved. About Us | Terms and Conditions